Exelixis
Exelixis is on a Mission to Help Cancer Patients Recover Stronger and Live Longer
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model system genetics, we established a broad drug discovery and development platform that has served as the foundation for our continued efforts to bring new cancer therapies to patients in need. Our discovery efforts have resulted in four commercially available products, CABOMETYX® (cabozantinib), COMETRIQ® (cabozantinib), COTELLIC® (cobimetinib) and MINNEBRO® (esaxerenone), and we have entered into partnerships with leading pharmaceutical companies to bring these important medicines to patients worldwide. Supported by revenues from our marketed products and collaborations, we are committed to prudently reinvesting in our business to maximize the potential of our pipeline. We are supplementing our existing therapeutic assets with targeted business development activities and internal drug discovery — all to deliver the next generation of Exelixis medicines and help patients recover stronger and live longer. Exelixis is a member of the Standard & Poor’s (S&P) MidCap 400 index, which measures the performance of profitable mid-sized companies.
The Exelixis Credo
We drive for results, so patients can survive and thrive.
We are resilient in the face of adversity, and tireless in advancing our science.
We celebrate our long history of prolific drug discovery and rigorous drug development.
We unite to launch innovative medicines for difficult-to-treat cancers.
We exist to give people hope – one drug, one patient at a time.
We are Exelixis.
Cancer is our cause. Make it yours, too.
We employ the best in biotech to discover, develop and commercialize medicines that help patients living with cancer recover stronger and live longer. Join our collective quest for oncology excellence and help us achieve our important and ambitious goals.
We’re expanding our teams company-wide in areas including Drug Discovery, Clinical Development, Commercial and Administration for our Alameda and Philadelphia locations.
Work with us in Alameda and Philadelphia!
Exelixis is headquartered in Alameda’s Waterfront at Harbor Bay in a large, modern campus with state-of-the-art lab space that provides room for continued growth. The company has also expanded East with a new location in the Philadelphia area focused on our discovery and development capabilities in addition to other business operational functions.
We’re Driven by an Ambitious Cause
At Exelixis, our focus and commitment is clear: to launch new medicines that give patients and their families hope for the future.
OUR VALUES
- Be Exceptional: Take the right action and lead others to do the right thing at the right time in the right way.
- Excel for Patients: Innovate to design solutions and remove barriers to show how much we care.
- Exceed Together: Apply rigor, resourcefulness and respect to maximize opportunities and deliver impactful results.
Search among Exelixis jobs
| Jobs: 11 - 20 of 127 |
Associate Technical Accounting Director
Alameda, California
SUMMARY/JOB PURPOSE: This person will be a key member of the Accounting department to supplement the Company's Technical Accounting and SEC reporting team. This person will have the primary responsibility for technical accounting guidance a...
23d
Alameda, California
SUMMARY/JOB PURPOSE: The Stock Plan Administrator will administer and manage all aspects of the company's equity compensation plan including transactions, record keeping, reconciliation and reporting. The Stock Plan Administrator will work ...
23d
Senior Staff Engineer - Cybersecurity
Alameda, California
SUMMARY/JOB PURPOSE: Join our highly skilled and rapidly growing cybersecurity team as a Senior Staff Engineer. In this role, you will be at the forefront of our cybersecurity operations, focusing on threat detection, incident response, and...
23d
Senior Oncology Account Manager
SUMMARY/JOB PURPOSE (Basic purpose of the job): As a Senior Oncology Account Manager at Exelixis, you will bring deep market knowledge and established relationships within your territory to drive strategic growth. This role is suited for a ...
23d
Alameda, California
SUMMARY/JOB PURPOSE: Exelixis is growing. Our IT Infrastructure needs to grow and evolve to continue to enable the business. We are looking for a Staff Engineer - DevOps to support the design and creation of cloud-based products and service...
23d
Senior Oncology Account Manager - Birmingham, Alabama
SUMMARY/JOB PURPOSE : As a Senior Oncology Account Manager at Exelixis, you will bring deep market knowledge and established relationships within your territory to drive strategic growth. This role is suited for a seasoned oncology sales pr...
23d
Regulatory Affairs Strategy Manager (Oncology)
Alameda, California
SUMMARY/JOB PURPOSE: Responsible for managing and maintaining existing Investigational New Drug (IND), Clinical Trial Application (CTA), New Drug Application (NDA), and Biologics Licensing Application (BLA) submissions and preparing amendme...
23d
Corporate Counsel - Commercial
Alameda, California
The Corporate Counsel - Commercial is responsible for providing commercialization legal support, advice and counsel in connection with planning, tactics and strategies undertaken primarily by the Commercial and Medical Affairs departments o...
23d
Pharmacovigilance Risk Management (PVRM) Medical Director
Alameda, California
SUMMARY/JOB PURPOSE: The PVRM Medical Director is responsible for the medical review of Individual Case Safety Reports (ICSRs) for Exelixis products and is involved with other safety deliverables (eg safety surveillance) for assigned projec...
23d
Associate Clinical Data Management Director
Alameda, California
SUMMARY/JOB PURPOSE: Provide oversight for the execution of data management activities at the program level (for an indication or for multiple oncology studies within an indication) from study start up through to regulatory submission. In c...
23d